Impaired Aortic Elastic Properties in Patients with Chronic Graft-versus-Host Disease
Orhan Dogdu M.D.,
Mehmet Gungor Kaya M.D., Mikail Yarlioglues M.D., Ali Dogan M.D., Idris Ardic M.D., Deniz Elcik M.D., Nihat Kalay M.D., Leylagul Kaynar M.D.,
Fatih Kurnaz M.D.,
Namik Kemal Eryol M.D.,
Orhan Dogdu M.D.
Department of Cardiology, Yozgat State Hospital Yozgat, Turkey
Search for more papers by this authorLeylagul Kaynar M.D.
Department of Hematology, Erciyes University School of Medicine Kayseri, Turkey
Search for more papers by this authorFatih Kurnaz M.D.
Department of Hematology, Erciyes University School of Medicine Kayseri, Turkey
Search for more papers by this authorOrhan Dogdu M.D.,
Mehmet Gungor Kaya M.D., Mikail Yarlioglues M.D., Ali Dogan M.D., Idris Ardic M.D., Deniz Elcik M.D., Nihat Kalay M.D., Leylagul Kaynar M.D.,
Fatih Kurnaz M.D.,
Namik Kemal Eryol M.D.,
Orhan Dogdu M.D.
Department of Cardiology, Yozgat State Hospital Yozgat, Turkey
Search for more papers by this authorLeylagul Kaynar M.D.
Department of Hematology, Erciyes University School of Medicine Kayseri, Turkey
Search for more papers by this authorFatih Kurnaz M.D.
Department of Hematology, Erciyes University School of Medicine Kayseri, Turkey
Search for more papers by this authorOrhan Dogdu, M.D., Yozgat State Hospital, Department of Cardiology, 66000 Yozgat, Turkey. Fax: +90 352 4373408; E-mail: [email protected]
Conflicts of interest: None.
Abstract
Objectives: Graft-versus-host disease (GVHD), which develops as a result of the immunologic response that donor T-lymphocytes generate against host tissue following hematopoietic stem cell transplantation (HSCT), is the leading cause of morbidity and mortality in these patients. The aim of this study is the investigate relation between aortic wall stiffness and duration of the disease in patients with chronic GVHD. Methods: The study population included 32 patients (18 men; mean age, 36.9 ± 12.5 years, and mean disease duration = 14.7 ± 2.9 months) who received HSCT and was diagnosed with GVHD and 44 patients (23 men; mean age, 35.2 ± 9.6 years, and mean disease duration = 13.5 ± 2.4 months) who did not develop GVHD following HSCT. All patients underwent baseline echocardiography before HSCT and were followed. After approximately 10–14 months following HSCT, these patients were divided into two groups based on whether they had developed chronic GVHD, and were compared to aortic stiffness parameters and cardiac functions. Results: There was no change in basal characteristics, laboratory and echocardiographic findings, and aortic stiffness parameters in both groups before HSCT (P > 0.05). After HSCT, the mean aortic strain and distensibility values of the chronic GVHD patients were significantly lower, compared with the non-GVHD patients (9.8 ± 3.2% vs. 12.9 ± 5.0%, P = 0.002 and 4.1 ± 1.5 × 10−6 cm2/dyn vs. 5.3 ± 2.1 × 10−6 cm2/dyn; P = 0.005, respectively). In addition, aortic stiffness index was increased in the chronic GVHD group compared with non-GVHD group (2.7 ± 1.7 vs. 2.0 ± 0.8, P = 0.03). Conclusion: Aortic stiffness measurements were significantly different in chronic GVHD group compared to non-GVHD group and these findings suggested useful explanation for the potential mechanism about the development of disease. (Echocardiography 2011;28:1011-1018)
References
- 1 Antin JH: Long-term care after hematopoietic-cell transplantation in adults. N Engl J Med 2002; 347: 36–42.
- 2 Deeg HJ: Delayed complications after hematopoietic transplantation. In ED Thomas, KG Blume, SJ Forman (eds): Hematopoietic cell transplantation. Malden , MA : Blackwell Science, Inc., 1999, pp. 776–788.
- 3 Kansu E, Sullivan KM: Late effects of hematopoietic stem cell transplantation; bone marrow transplantation. Hematology 2000; 5: 209–222.
- 4 Treleaven J: Late effects of bone marrow transplantation. In J Trelevaen, P Wiernik (eds): Color atlas and text of bone marrow transplantation, 1st Ed . London : Mosby-Wolfe, 1995, pp. 193–199.
- 5 Pollard M, Chang CF, Srivastava KK: The role of microflora in development of graft-versus-host disease. Transplant Proc 1976; 8: 533–536.
- 6 Sullivan KM, Shulman HM, Storb R, et al: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276
- 7 Asanuma Y, Oeser A, Shintani AK, et al: Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407–2415.
- 8
Del Rincon I,
Williams K,
Stern MP, et al: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.
Arthritis Rheum
2001; 44: 2737–2745.
10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- 9 Keles T, Durmaz T, Bayram NA, et al: Effect of continuous positive airway pressure therapy on aortic stiffness in patients with obstructive sleep apnea syndrome. Echocardiography 2009; 26: 1217–2124.
- 10 Stefanadis C, Stratos C, Boudoulas H, et al: Distensibility of the ascending aorta: Comparison of invasive and non-invasive techniques in healthy men and in men with coronary artery disease. Eur Heart J 1990; 11: 990–996.
- 11 Suh SY, Kim EJ, Choi CU, et al: Aortic upper wall tissue Doppler image velocity: Relation to aortic elasticity and left ventricular diastolic function. Echocardiography 2009; 26: 1069–1074.
- 12 Mäki-Petäjä KM, Booth AD, Hall FC, et al: Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007; 50: 852–858.
- 13 Tavil Y, Oztürk MA, Ureten K, et al: Assessment of aortic wall stiffness in patients with Familial Mediterranean Fever. Joint Bone Spine 2008; 75: 280–285.
- 14 Okubo M, Ino T, Takahashi K, et al: Age dependency of stiffness of the abdominal aorta and the mechanical properties of the aorta in Kawasaki disease in children. Pediatr Cardiol 2001; 22: 198–203.
- 15 Kiotsekoglou A, Moggridge JC, Saha SK, et al: Assessment of aortic stiffness in marfan syndrome using two-dimensional and Doppler echocardiography. Echocardiography 2011; 28: 29–37.
- 16 Cypiene A, Kovaite M, Venalis A, et al: Arterial wall dysfunction in systemic lupus erythematosus. Lupus 2009; 18: 522–529.
- 17 Quinones MA, Otto CM, Stoddard M, et al: Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167–184
- 18 Ozdogru I, Tanriverdi F, Dogan A, et al: Impaired longitudinal myocardial velocities in patients with growth hormone deficiency improves after hormone replacement therapy. J Am Soc Echocardiogr 2007; 20: 1093–1099.
- 19 Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977; 55: 613–618.
- 20 McQuillan BM, Picard MH, Leavitt M, et al: Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001; 104: 2797–2802.
- 21 Nagueh SF, Appleton CP, Gillebert TC, et al: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107–133.
- 22 Tavil Y, Kanbay A, Sen N, et al: The relationship between aortic stiffness and cardiac function in patients with obstructive sleep apnea, independently from systemic hypertension. J Am Soc Echocardiogr. 2007; 20: 366–372.
- 23 Kaya MG, Ozdogru I, Inanc T, et al: Aortic stiffness formula. Am J Hypertens 2007; 20: 816; author reply 816–817.
- 24 Hundley WG, Kitzman DW, Morgan TM, et al: Cardiac cycle dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001; 38: 796–802.
- 25 Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236–1241
- 26 Stefanadis C, Dernellis J, Tsiamis E, et al: Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischemic heart disease. Eur Heart J 2000; 21: 390–396.
- 27 Ng WF, Fantin F, Ng C, et al; Takayasu's arteritis: A cause of prolonged arterial stiffness. Rheumatology 2006; 45: 741–745.
- 28 Tunc SE, Dogan A, Gedikli O, et al: Assessment of aortic stiffness and ventricular diastolic functions in patients with Behçet's disease. Rheumatol Int 2005; 25: 447–451.
- 29 Timár O, Soltész P, Szamosi S, et al: Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 2008; 35: 1329–1333.
- 30 Edwards NC, Steeds RP, Stewart PM, et al: Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: A randomized controlled trial. J Am Coll Cardiol 2009; 54: 505–512.
- 31 Ardic I, Kaya MG, Yarlioglues M, et al: Impaired aortic elastic properties in normotensive patients with psoriasis. Blood Press 2010.
- 32 O’Rourke MF, Nichols WW: Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension 2005; 45: 652–658.
- 33 Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695.
- 34 Danesh J, Wheeler JG, Hirschfield GM, et al: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387–1397.
- 35 Danesh J, Erqou S, Walker M, et al: The Emerging Risk Factors Collaboration: Analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007; 22: 839–869.
- 36 Danesh J, Kaptoge S, Mann AG, et al: Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 2008; 5: e(78).
- 37 Hwang SJ, Ballantyne CM, Sharrett AR, et al: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The atherosclerosis risk in communities (ARIC) study. Circulation 1997; 96: 4219–4225.
- 38 Klocke R, Cockcroft JR, Taylor GJ, et al: Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 2003; 62: 414–418.
- 39 Wong M, Toh L, Wilson A, et al: Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 2003; 48: 81–89.
- 40 Selzer F, Sutton-Tyrrell K, Fitzgerald S, et al: Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001; 37: 1075–1082.
- 41 Ferrara JL, Deeg HJ: Graft versus host disease. N Engl J Med 1991; 324: 667–674.
- 42 Holler E: Cytokines, viruses, and graft-versus-host disease. Curr Opin Hematol 2002; 9: 479–484.
- 43 Jadus MR, Wepsic HT: The role of cytokines in graft versus host reactions and disease. Bone Marrow Transplant 1992; 10: 1–14.
- 44 Nakamura H, Komatsu K, Ayaki M, et al: Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Allergy Clin Immunol 2000; 106: S45–50.
- 45 Rackley C, Schultz KR, Goldman FD, et al: Cardiac manifestations of graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 773–780.
- 46 Moyssakis I, Gialafos E, Vassiliou VA, et al: Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol 2009; 38: 216–221.
- 47 Scherrer U, Vissing SF, Morgan BJ, et al: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990; 323: 693–699.
- 48 Stefanidis C, Dernellis J, Vavuranakis M, et al: Effects of ventricular pacing-induced tachycardia on aortic mechanics in man. Cardiovasc Res 1998; 39: 506–514.
- 49 Espino G, Denney J, Furlong T, et al: Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute G.Bone Marrow Transplant 2001; 28: 1097–1103.
- 50 Gelpi RJ, Gao S, Zhai P, et al: Genetic inhibition of calcineurin induces diastolic dysfunction in mice with chronic pressure overload. Am J Physiol Heart Circ Physiol 2009; 297: H1814–1819.
- 51 Rudominer RL, Roman MJ, Devereux RB, et al: Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum 2009; 60: 22–29.
- 52 Liang KP, Myasoedova E, Crowson CS, et al: Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1665–1670.
- 53 Lartaud-Idjouadiene I, Lompre AM, Kieffer P, et al: Cardiac consequences of prolonged exposure to an isolated increase in aortic stiffness. Hypertension 1999; 34: 63–69.
- 54 London GM, Guerin A: Influence of arterial pulse and reflected waves on blood pressure and cardiac function. Am Heart J 1999; 138: 220–224.
- 55 Ohtsuka S, Kakihana M, Watanabe H, et al: Alterations in left ventricular wall stress and coronary circulation in patients with isolated systolic hypertension. J Hypertens 1996; 14: 1349–1355.
- 56 Raev DC: Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 1994; 17: 633–639.
Citing Literature
